5
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Effective Chelation Therapy after Incorporation of Neptunium-239 in Rats

&
Pages 955-959 | Received 28 May 1986, Accepted 01 Aug 1986, Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

M.H. Henge-Napoli, M. Archimbaud, E. Ansoborlo, H. Metivier & P. Gourmelon. (1995) Efficacy of 3,4,3-LIHOPO for Reducing the Retention of Uranium in Rat after Acute Administration. International Journal of Radiation Biology 68:4, pages 389-393.
Read now

Articles from other publishers (4)

Manohar Mahato, Nicholas E. Sherman, N. Kiran Kumar Mudnakudu, Nitin Joshi, Elisabeth Briand, Jeffrey M. Karp & Praveen Kumar Vemula. 2018. Metal Allergy. Metal Allergy 227 246 .
Elias Fattal, Nicolas Tsapis & Guillaume Phan. (2015) Novel drug delivery systems for actinides (uranium and plutonium) decontamination agents. Advanced Drug Delivery Reviews 90, pages 40-54.
Crossref
Patricia W. Durbin. (2008) LAURISTON S. TAYLOR LECTURE: THE QUEST FOR THERAPEUTIC ACTINIDE CHELATORS. Health Physics 95:5, pages 465-492.
Crossref
P Fritsch, B Ramounet, R Burgada, H Métivier, F Paquet & J.L Poncy. (1998) Experimental approaches to improve the available chelator treatments for Np decorporation. Journal of Alloys and Compounds 271-273, pages 89-92.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.